{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:52:03Z","timestamp":1792324323300,"version":"4.4.0"},"reference-count":219,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.autrev.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T07:45:50Z","timestamp":1501659950000},"page":"1058-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Yong-chao","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jss.2005.07.033","article-title":"Regulatory T-cells and autoimmunity","volume":"130","author":"Ni Choileain","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.autrev.2017.08.001_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10753-016-0470-8","article-title":"Foxp3, regulatory T cell, and autoimmune diseases","volume":"40","author":"Tao","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2012.0514","article-title":"Impairment of regulatory T-cell function in autoimmune thyroid disease","volume":"23","author":"Glick","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2017.08.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2017.34","article-title":"T cells and autoimmune kidney disease","author":"Suarez-Fueyo","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1361.044","article-title":"IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia","volume":"1051","author":"Toriani-Terenzi","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.4049\/jimmunol.1600133","article-title":"New murine model of early onset autoimmune thyroid disease\/hypothyroidism and autoimmune exocrinopathy of the salivary gland","volume":"197","author":"Kayes","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2017.08.001_bb0040","first-page":"431","article-title":"A study on FoxP3 and Tregs in paired samples of peripheral blood and synovium in rheumatoid arthritis","volume":"40","author":"Shalini","year":"2015","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0045","first-page":"78","article-title":"Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation","volume":"18","author":"Li","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.febslet.2011.07.043","article-title":"Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"585","author":"Chavele","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2017.08.001_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.revmed.2009.03.364","article-title":"Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjogren's syndrome","volume":"31","author":"Bernard","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1422.007","article-title":"Regulatory T cells and systemic lupus erythematosus","volume":"1108","author":"Parietti","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2567.2008.02937.x","article-title":"Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus","volume":"127","author":"Suen","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imm.12439","article-title":"Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjogren syndrome","volume":"145","author":"Lieberman","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.08.001_bb0075","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.3760\/cma.j.issn.0366-6999.20141395","article-title":"Correlation of Th17 cells and CD4(+)CD25(+) regulatory T cells with clinical parameters in patients with systemic sclerosis","volume":"127","author":"Jiang","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2017.08.001_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/14397595.2014.899736","article-title":"Decreased expression of Runx1 and lowered proportion of Foxp3(+) CD25(+) CD4(+) regulatory T cells in systemic sclerosis","volume":"25","author":"Kataoka","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1752-8062.2011.00265.x","article-title":"Regulatory T-cell detection by flow cytometry and systemic sclerosis","volume":"4","author":"Khan","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nri3155","article-title":"Selection of regulatory T cells in the thymus","volume":"12","author":"Hsieh","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0105","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/ker183","article-title":"Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept","volume":"50","author":"Blache","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40744-016-0032-4","article-title":"Emerging therapies for rheumatoid arthritis","volume":"3","author":"Kalden","year":"2016","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2017.08.001_bb0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.drudis.2007.05.002","article-title":"Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy","volume":"12","author":"Bayry","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.autrev.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","article-title":"Global natural regulatory T cell depletion in active systemic lupus erythematosus","volume":"175","author":"Miyara","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2016.01.002","article-title":"Induction of regulatory T cells: a role for probiotics and prebiotics to suppress autoimmunity","volume":"15","author":"Dwivedi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"3694957","DOI":"10.1155\/2016\/3694957","article-title":"Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Qiao","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.autrev.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2009.2","article-title":"Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host","volume":"6","author":"Qin","year":"2009","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/intimm\/dxh221","article-title":"CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4","volume":"17","author":"Kataoka","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation","volume":"19","author":"Salomon","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","article-title":"CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor","volume":"16","author":"McHugh","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri1030","article-title":"Immunoregulation in the tissues by gammadelta T cells","volume":"3","author":"Hayday","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1568-9972(02)00065-4","article-title":"CD8+ T suppressor cells are back to the game: are they players in autoimmunity?","volume":"1","author":"Filaci","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0185","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.humimm.2006.02.020","article-title":"Immunoregulation of autoimmunity by natural killer T cells","volume":"66","author":"Linsen","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2013.07.005","article-title":"T lymphocyte abnormalities in juvenile systemic sclerosis patients","volume":"149","author":"Reiff","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0205","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.168.3.1080","article-title":"CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses","volume":"168","author":"Kingsley","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.iy.11.040193.001333","article-title":"The IL-2 receptor complex: its structure, function, and target genes","volume":"11","author":"Minami","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1074-7613(00)80246-0","article-title":"IL-15: a pleiotropic cytokine with diverse receptor\/signaling pathways whose expression is controlled at multiple levels","volume":"4","author":"Tagaya","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb0220","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.161.5.2141","article-title":"Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen","volume":"161","author":"Dooms","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0230","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.188.10.1849","article-title":"Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells","volume":"188","author":"Chen","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0235","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.4049\/jimmunol.166.4.2394","article-title":"A critical role for CD2 in both thymic selection events and mature T cell function","volume":"166","author":"Sasada","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0240","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.V89.4.1308","article-title":"CD2 regulates the positive selection and function of antigen-specific CD4\u2212 CD8+ T cells","volume":"89","author":"Teh","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.08.001_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389203013381251","article-title":"Structural biology of the cell adhesion protein CD2: alternatively folded states and structure-function relation","volume":"2","author":"Yang","year":"2001","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12000","article-title":"Piecing together the family portrait of TCR-CD3 complexes","volume":"250","author":"Kuhns","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0255","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.celrep.2016.02.081","article-title":"Structural model of the extracellular assembly of the TCR-CD3 complex","volume":"14","author":"Natarajan","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2017.08.001_bb0260","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0198-8859(91)90047-D","article-title":"Down regulation of T-cell adhesion by CD4","volume":"31","author":"Mazerolles","year":"1991","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0265","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0270","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.08.001_bb0275","first-page":"537","article-title":"CD45RO expression on bovine T cells: relation to biological function","volume":"86","author":"Bembridge","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.08.001_bb0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(90)90085-N","article-title":"Role of the CD28 receptor in T-cell activation","volume":"11","author":"June","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2017.08.001_bb0285","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.4049\/jimmunol.157.10.4363","article-title":"Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation","volume":"157","author":"Pinchuk","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0290","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.4049\/jimmunol.163.8.4150","article-title":"Expression, regulation, and function of B cell-expressed CD154 in germinal centers","volume":"163","author":"Grammer","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0295","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.08.001_bb0300","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/1521-4141(2002010)32:10<2905::AID-IMMU2905>3.0.CO;2-6","article-title":"Inhibition of TCR-mediated shedding of L-selectin (CD62L) on human and mouse CD4+ T cells by metalloproteinase inhibition: analysis of the regulation of Th1\/Th2 function","volume":"32","author":"Savage","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0305","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/90942","article-title":"Signaling through OX40 (CD134) breaks peripheral T-cell tolerance","volume":"7","author":"Bansal-Pakala","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0310","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.vaccine.2005.07.108","article-title":"Regulation of CD4 T cell memory by OX40 (CD134)","volume":"24","author":"Salek-Ardakani","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2017.08.001_bb0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4419-6451-9_5","article-title":"The role of OX40 (CD134) in T-cell memory generation","volume":"684","author":"Weinberg","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0320","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity*","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0325","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.molimm.2010.03.017","article-title":"CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch","volume":"47","author":"Hoff","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0330","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1084\/jem.20031058","article-title":"CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function","volume":"199","author":"Pandiyan","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0335","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.imbio.2016.03.007","article-title":"PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis","volume":"221","author":"Chiku","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2017.08.001_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128523","article-title":"PD-1 and Tim-3 pathways regulate CD8+ T cells function in atherosclerosis","volume":"10","author":"Qiu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.08.001_bb0345","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.4049\/jimmunol.0801167","article-title":"TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal","volume":"182","author":"Mercier","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0350","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.1003715","article-title":"TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function","volume":"187","author":"Nyirenda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0355","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function","volume":"309","author":"Peng","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.08.001_bb0360","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/eji.201343451","article-title":"Modulation of Treg cells\/T effector function by GITR signaling is context-dependent","volume":"43","author":"Ephrem","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","article-title":"GITR+ regulatory T cells in the treatment of autoimmune diseases","volume":"14","author":"Petrillo","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.191.1.77","article-title":"The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules","volume":"191","author":"Warnock","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0375","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.194.10.1541","article-title":"CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin","volume":"194","author":"Reiss","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.191.1.61","article-title":"The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules","volume":"191","author":"Stein","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0385","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.molimm.2009.04.004","article-title":"LFA-1 is critical for regulatory T cell homeostasis and function","volume":"46","author":"Wohler","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0390","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4049\/jimmunol.144.12.4579","article-title":"The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells","volume":"144","author":"Van Seventer","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0395","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.coi.2010.01.001","article-title":"Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)","volume":"22","author":"Simpson","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0400","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201242794","article-title":"ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection","volume":"43","author":"Redpath","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09674845.2016.1264704","article-title":"Potential route of Th17\/Treg cell dynamics in targeting type 1 diabetes and rheumatoid arthritis: an autoimmune disorder perspective","volume":"74","author":"Karri","year":"2017","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb0415","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.08.001_bb0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.08.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2017.02.005","article-title":"NK cell subsets in autoimmune diseases","author":"Zhang","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.08.001_bb0430","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2004.04.003","article-title":"CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction","volume":"112","author":"Trzonkowski","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0435","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","article-title":"CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer","volume":"176","author":"Smyth","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0440","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1084\/jem.20041522","article-title":"NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer","volume":"200","author":"Smyth","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0445","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.146.10.3289","article-title":"Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta","volume":"146","author":"Smyth","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0450","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.humimm.2004.12.006","article-title":"Modulation of monocyte\/macrophage function by human CD4+CD25+ regulatory T cells","volume":"66","author":"Taams","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0455","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4049\/jimmunol.165.3.1175","article-title":"Anergic T cells inhibit the antigen-presenting function of dendritic cells","volume":"165","author":"Vendetti","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0460","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.08.001_bb0465","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X","article-title":"CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells","volume":"30","author":"Cederbom","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0470","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.autrev.2015.04.006","article-title":"Humoral autoimmunity: a failure of regulatory T cells?","volume":"14","author":"Dhaeze","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.11.004","article-title":"A novel method for assaying human regulatory T cell direct suppression of B cell effector function","volume":"441","author":"Weingartner","year":"2017","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2017.08.001_bb0480","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.08.001_bb0485","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0490","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2013.06.004","article-title":"Promotion and prevention of autoimmune disease by CD8+ T cells","volume":"45","author":"Gravano","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.08.001_bb0495","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1517\/14712590903020759","article-title":"Treating autoimmune disease by targeting CD8(+) T suppressor cells","volume":"9","author":"Konya","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.autrev.2017.08.001_bb0500","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.2130","article-title":"A CD8+ T cell transcription signature predicts prognosis in autoimmune disease","volume":"16","author":"McKinney","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0505","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humimm.2008.08.283","article-title":"Inhibitory CD8+ T cells in autoimmune disease","volume":"69","author":"Suzuki","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0510","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0515","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4049\/jimmunol.178.3.1388","article-title":"Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets","volume":"178","author":"Wong","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0520","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.186.7.989","article-title":"Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice","volume":"186","author":"Kagi","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0525","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI19727","article-title":"CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism","volume":"113","author":"Dai","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.08.001_bb0530","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.08.001_bb0535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0540","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.4049\/jimmunol.1401936","article-title":"PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells","volume":"194","author":"Park","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0545","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0550","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4049\/jimmunol.167.3.1137","article-title":"Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells","volume":"167","author":"Piccirillo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0555","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1074-7613(04)00054-8","article-title":"Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection","volume":"20","author":"Dittmer","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb0560","first-page":"615","article-title":"Pre-treatment with cyclophosphamide or OX40 (CD134) costimulation targeting regulatory T cell function enhances the anti-tumor immune effect of adoptively transferred CD8+ T cells from wild-type mice","volume":"2","author":"Ueki","year":"2009","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2017.08.001_bb0565","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.immuni.2015.05.023","article-title":"Quiescence of memory CD8(+) T cells is mediated by regulatory T cells through inhibitory receptor CTLA-4","volume":"42","author":"Kalia","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb0570","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-014-3262-4","article-title":"Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes","volume":"57","author":"Favaro","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2017.08.001_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1900\/RDS.2005.2.9","article-title":"The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy","volume":"2","author":"Thomas","year":"2005","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.autrev.2017.08.001_bb0580","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4049\/jimmunol.1201362","article-title":"The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes","volume":"190","author":"Stumpf","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0585","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0590","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0595","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa0804328","article-title":"GAD treatment and insulin secretion in recent-onset type 1 diabetes","volume":"359","author":"Ludvigsson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029008","article-title":"Long-lasting immune responses 4years after GAD-alum treatment in children with type 1 diabetes","volume":"6","author":"Axelsson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.08.001_bb0605","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.2337\/dc11-1406","article-title":"Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide","volume":"34","author":"Haller","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2017.08.001_bb0610","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbmt.2013.04.011","article-title":"Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with type 1 diabetes","volume":"19","author":"Haller","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.autrev.2017.08.001_bb0615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-10-3","article-title":"Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0620","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2years after onset of type 1 diabetes","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2017.08.001_bb0625","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0630","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2017.08.001_bb0635","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2017.08.001_bb0640","first-page":"17","article-title":"Tregs and rheumatoid arthritis","volume":"33","author":"Anderson","year":"2008","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2017.08.001_bb0645","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/s10165-011-0476-x","article-title":"Abrogation of Treg function deteriorates rheumatoid arthritis","volume":"22","author":"Yamagiwa","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0650","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/annrheumdis-2013-204377","article-title":"Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis","volume":"74","author":"Zhou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb0655","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3346\/jkms.2012.27.9.1009","article-title":"Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0660","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.08.001_bb0665","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network","volume":"107","author":"de Kleer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.08.001_bb0670","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1073\/pnas.0400061101","article-title":"Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis","volume":"101","author":"Prakken","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.08.001_bb0675","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.smim.2011.07.004","article-title":"Therapeutic potential of Tregs to treat rheumatoid arthritis","volume":"23","author":"Wright","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0680","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.08.001_bb0685","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.08.001_bb0690","doi-asserted-by":"crossref","first-page":"R235","DOI":"10.1186\/ar4078","article-title":"Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL\/lpr autoimmune mice and BDF1 hybrid mice","volume":"14","author":"Xiao","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.08.001_bb0695","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10067-016-3197-x","article-title":"Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus","volume":"35","author":"Handono","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0700","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar4188","article-title":"CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice","volume":"15","author":"Weigert","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.08.001_bb0705","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0710","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","article-title":"Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE","volume":"74","author":"Humrich","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb0715","first-page":"65","article-title":"The importance of minor salivary gland biopsy in Sjogren syndrome diagnosis and the clinicopathological correlation","volume":"32","author":"Serin","year":"2016","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.autrev.2017.08.001_bb0720","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00002281-200309000-00007","article-title":"New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers","volume":"15","author":"Hansen","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0725","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.4049\/jimmunol.0804251","article-title":"Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity","volume":"183","author":"Wheeler","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0730","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2006.10.005","article-title":"Controlling autoimmunity\u2013lessons from the study of red blood cells as model antigens","volume":"108","author":"Barker","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2017.08.001_bb0735","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-12-4692","article-title":"CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia","volume":"105","author":"Mqadmi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.08.001_bb0740","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0745","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0750","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb0755","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb0760","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-012-2000-x","article-title":"The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis","volume":"31","author":"Papp","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0765","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2008.03810.x","article-title":"Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes","volume":"154","author":"Lawson","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0770","first-page":"34","article-title":"Lower percentages of T regulatory cells in children with type 1 diabetes - preliminary report","volume":"15","author":"Luczynski","year":"2009","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"10.1016\/j.autrev.2017.08.001_bb0775","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clim.2008.10.005","article-title":"APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes","volume":"130","author":"Jin","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0780","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.08.001_bb0785","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db10-1201","article-title":"Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes","volume":"60","author":"Badami","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2017.08.001_bb0790","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12020-009-9166-2","article-title":"Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis","volume":"35","author":"Alonso","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2017.08.001_bb0795","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2017.08.001_bb0800","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2017.08.001_bb0805","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0810","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00441-009-0900-0","article-title":"Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls","volume":"339","author":"Glisic","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2017.08.001_bb0815","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0820","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cei.12116","article-title":"CD4(+) CD45RA(\u2212) FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes","volume":"173","author":"Haseda","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0825","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2004.11.004","article-title":"CD4+CD25high regulatory T cells in human autoimmune diabetes","volume":"24","author":"Putnam","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.08.001_bb0835","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4103\/2230-8210.102998","article-title":"Regulatory T cells in children with recently diagnosed type 1 diabetes","volume":"16","author":"Zahran","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.autrev.2017.08.001_bb0840","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fimmu.2017.00300","article-title":"Novel senescent regulatory T-cell subset with impaired suppressive function in rheumatoid arthritis","volume":"8","author":"Fessler","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0845","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.08.001_bb0850","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.08.001_bb0855","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1196\/annals.1361.095","article-title":"Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab","volume":"1051","author":"Toubi","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb0860","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis","volume":"140","author":"Mottonen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0865","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/immu.200390024","article-title":"Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis","volume":"33","author":"Cao","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0870","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-3083.2005.01656.x","article-title":"The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis","volume":"62","author":"Liu","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0875","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.08.001_bb0880","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid","volume":"50","author":"van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.08.001_bb0885","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","article-title":"CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis","volume":"253","author":"Han","year":"2008","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0890","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodriguez-Reyna","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.08.001_bb0895","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0300-9475.2004.01370.x","article-title":"Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus","volume":"59","author":"Liu","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0900","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","article-title":"Quantification of regulatory T cells in patients with systemic lupus erythematosus","volume":"21","author":"Crispin","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.08.001_bb0905","first-page":"25","article-title":"Diminished CD4+CD25+ T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus","volume":"12","author":"Fathy","year":"2005","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0910","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2005.02306.x","article-title":"Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus","volume":"117","author":"Lee","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.08.001_bb0915","first-page":"570","article-title":"Clinical significance of CD4+CD25+ T cells in peripheral blood of patients in systemic lupus erythematosus","volume":"44","author":"Yang","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.autrev.2017.08.001_bb0920","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2007.074690","article-title":"Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis","volume":"67","author":"Bonelli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb0925","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0930","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","article-title":"Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus","volume":"47","author":"Lee","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.08.001_bb0935","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.23556","article-title":"Reduced CD4+,CD25\u2212 T cell sensitivity to the suppressive function of CD4+,CD25high,CD127\u2212\/low regulatory T cells in patients with active systemic lupus erythematosus","volume":"58","author":"Venigalla","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.08.001_bb0940","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2249.2008.03665.x","article-title":"Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis","volume":"153","author":"Yates","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0945","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.22699","article-title":"Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus","volume":"56","author":"Franz","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.08.001_bb0950","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-72005-0_12","article-title":"Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus","volume":"601","author":"Lyssuk","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0955","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0961203307080226","article-title":"Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus","volume":"16","author":"Barath","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.08.001_bb0960","first-page":"453","article-title":"Expression of CD4+ CD25+ CD127(low\/\u2212) T cells in patients with systemic lupus erythematosus","volume":"88","author":"Zhao","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.autrev.2017.08.001_bb0965","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00296-010-1427-0","article-title":"Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus","volume":"31","author":"Habibagahi","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.08.001_bb0970","first-page":"307","article-title":"Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjogren's syndrome","volume":"13","author":"Ichikawa","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb0975","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4081\/reumatismo.2012.293","article-title":"Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjogren's syndrome: correlation with disease activity","volume":"64","author":"Alunno","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2017.08.001_bb0980","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.08.001_bb0985","first-page":"1034","article-title":"Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjogren's syndrome","volume":"87","author":"Li","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.autrev.2017.08.001_bb0990","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2009.03544.x","article-title":"Regulatory T cells in Graves' disease","volume":"71","author":"Pan","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.autrev.2017.08.001_bb0995","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11596-006-0515-6","article-title":"Changes of regulatory T cells in Graves' disease","volume":"26","author":"Wang","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb1000","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1005","first-page":"11","article-title":"Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets","volume":"2","author":"Paggi","year":"1998","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2017.08.001_bb1010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0042-122780","article-title":"Decreased frequencies of peripheral blood CD4+CD25+CD127\u2212Foxp3+ in patients with Graves' disease and Graves' orbitopathy: enhancing effect of insulin growth factor-1 on Treg cells","volume":"49","author":"Pawlowski","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2017.08.001_bb1015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2012.751981","article-title":"Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases","volume":"46","author":"Bossowski","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb1020","first-page":"1190","article-title":"Abnormal proportions of immune regulatory cells and their subsets in peripheral blood of patients with Graves' disease","volume":"30","author":"He","year":"2014","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.autrev.2017.08.001_bb1025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5603\/FHC.2014.0008","article-title":"Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes","volume":"52","author":"Klatka","year":"2014","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1507\/endocrj.EJ16-0108","article-title":"Implications of FoxP3-positive and -negative CD4(+) CD25(+) T cells in Graves' ophthalmopathy","volume":"63","author":"Matsuzawa","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.autrev.2017.08.001_bb1035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916934.2013.879862","article-title":"Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets","volume":"47","author":"Klatka","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2017.08.001_bb1040","first-page":"297","article-title":"Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia","volume":"21","author":"Ahmad","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000109295","article-title":"Progressive derangement of the T cell compartment in a case of Evans syndrome","volume":"145","author":"Giovannetti","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1050","first-page":"859","article-title":"A case of Evans' syndrome in which CD4+CD45RA+ cells markedly decreased in its active phase","volume":"34","author":"Iwase","year":"1993","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.autrev.2017.08.001_bb1055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.08.001_bb1060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1065","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2010.06.004","article-title":"Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes","volume":"137","author":"Giovannetti","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1075","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1136\/ard.2010.129999","article-title":"Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis","volume":"69","author":"Broen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb1080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.52.4.272","article-title":"Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity","volume":"52","author":"Fiocco","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.08.001_bb1085","doi-asserted-by":"crossref","first-page":"390563","DOI":"10.1155\/2013\/390563","article-title":"Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease","volume":"2013","author":"Cordiali-Fei","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2006.08.003","article-title":"CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis","volume":"180","author":"Kumar","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.08.001_bb1095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:53:46Z","timestamp":1719356026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217302070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":219,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1568997217302070"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.08.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}